98%
921
2 minutes
20
The main objectives of this study were to investigate the concentration and lifetime cancer risk and hazard index of trihalomethanes (THMs) through multiple routes like oral ingestion, dermal absorption, and inhalation exposure in the water samples collected at water treatment plant endpoints. Bromoform has been found in highest concentration followed by chloroform. A lesser concentration of dibromochloromethane has been found than dichlorobromomethane in most of the studied water, which is an unusual scenario, in spite of the high concentration of bromide in the water which can be attributed to the formation, speciation, and distribution of THMs in the breakpoint chlorination curve. Among the three pathways studied, inhalation contributed 80-90% of the total risk followed by oral exposure and dermal contact. Chloroform was found to be the major THM which is having cancer risk in its gaseous form whereas bromoform contributed highest cancer risk through oral ingestion. The average hazard index of total THMs through oral route was higher than unity, indicating high noncarcinogenic risk. The discrepancy between the three exposure pathways may be attributed to different concentration and speciation of THMs present in the waters. The sensitivity analysis by tornado diagram confirmed the highest positive impact of chloroform to the total cancer risk and, indirectly, confirmed inhalation as the major pathway of exposure. This study suggests the modification of the regulatory issues related to THMs based on the health risk associated with each THM and exposure pathway.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10661-010-1677-z | DOI Listing |
Pediatr Blood Cancer
September 2025
Acute Myeloid Leukemia Sub-Committee, Association of Childhood Leukemia Study (JACLS), Japan.
Background: Relapsed or refractory cases of pediatric acute myeloid leukemia (AML) have poor outcomes despite advancements in chemotherapy and hematopoietic stem cell transplantation (HSCT). While a second HSCT is often a salvage option, its outcomes vary widely, and prognostic factors remain unclear.
Objectives: This study aimed to evaluate outcomes and identify prognostic factors in pediatric patients with AML who underwent multiple HSCTs.
Pediatr Blood Cancer
September 2025
Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Moyamoya syndrome (MMS) is a chronic vasculopathy characterized by progressive stenosis of intracerebral arteries, leading to an increased risk of stroke. Children with Down syndrome (DS) are at an increased risk of co-occurring medical conditions, including MMS and leukemia. We report four patients with the triad of DS, MMS, and acute lymphoblastic leukemia (ALL).
View Article and Find Full Text PDFAnn Hematol
September 2025
Centre on Aging and Mobility, University of Zurich, Zurich, Switzerland.
While frailty and anemia are prevalent conditions in aging linked to adverse outcomes, their relationship remains understudied in generally healthy older adults. We conducted a post-hoc observational study among all participants of DO-HEALTH, the largest European clinical trial designed to support healthy aging. Our analysis examined whether baseline hemoglobin levels and anemia are associated with being at least pre-frail at baseline and any yearly follow-up time point over three years.
View Article and Find Full Text PDFUrol Oncol
September 2025
Department of Urology, Columbia University Irving Medical Center, New York, NY.
Objective: To evaluate the role of Rescue BCG in the treatment of BCG-unresponsive nonmuscle-invasive bladder cancer (NMIBC), in order to inform clinical decision-making especially when access to alternative therapies is limited.
Methods: From an institutional database, patients who met the criteria of BCG-unresponsive NMIBC between 2002 and 2023 were identified and sorted into 2 cohorts: those who received additional BCG therapy immediately after BCG-unresponsive designation and those who received alternative treatments such as intravesical chemotherapy and radical cystectomy. Primary endpoint was progression-free survival (PFS).
Brachytherapy
September 2025
Department of Radiological Sciences, School of Health Sciences, Fukushima Medical University, 10-6 Sakaemachi, Fukushima, Fukushima, 960-8516, Japan.
Purpose: This study presents the dose-based intra-preplan (DIP) method for intracavitary/interstitial brachytherapy (IC/ISBT) in cervical cancer, optimizing catheter configurations based on dose distribution. This study aimed to assess the DIP method's clinical feasibility and efficacy.
Methods And Materials: The DIP method incorporates the implant modeling function and the hybrid inverse planning optimization algorithm in Oncentra Brachy.